Trial description:
A phase III randomised trial investigating the combination of dose-fractionated chemotherapy & bevacizumab compared to either strategy alone for the first line treatment of women with newly diagnosed high risk stage III-IV epithelial ovarian, fallopian tube or primary peritoneal cancer
Contact name:
Dr Christine Parkinson
Trial start date:
Wednesday, February 8, 2012
Trial end date:
Tuesday, December 31, 2019
Trial tumour type:
Gynaecological
Show on Radiotherapy:
No
